BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2437605)

  • 1. Effect of benzo[c]phenanthridine alkaloids on reverse transcriptase and their binding property to nucleic acids.
    Kakiuchi N; Hattori M; Ishii H; Namba T
    Planta Med; 1987 Feb; 53(1):22-7. PubMed ID: 2437605
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of reverse transcriptase activity by benzophenanthridine alkaloids.
    Sethi ML
    Lloydia; 1979; 42(2):187-96. PubMed ID: 88001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of reverse transcriptase activity by benzophenanthridine alkaloids.
    Sethi ML
    J Nat Prod; 1979; 42(2):187-96. PubMed ID: 91665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mammalian and oncornavirus nucleic acid polymerase activities by alkoxybenzophenanthridine alkaloids.
    Sethi VS
    Cancer Res; 1976 Jul; 36(7 PT 1):2390-5. PubMed ID: 58719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kinetic analysis of interaction of human immunodeficiency virus reverse transcriptase with alkaloids].
    Gudima SO; Memelova LV; Borodulin VB; Pokholok DK; Mednikov BM; Tolkachev ON; Kochetkov SN
    Mol Biol (Mosk); 1994; 28(6):1308-14. PubMed ID: 7533889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the affinity of new N atom-containing tumor inhibitors for nucleic acids.
    Nagao Y; Sano S; Miyasaka T; Ochiai M; Fuji K; Fujita E; Ishii H
    Nucleic Acids Symp Ser; 1985; (16):37-40. PubMed ID: 4088881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chiral discrimination of enantiomeric 2'-deoxythymidine 5'-triphosphate by HIV-1 reverse transcriptase and eukaryotic DNA polymerases.
    Yamaguchi T; Iwanami N; Shudo K; Saneyoshi M
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1023-7. PubMed ID: 7513992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycitone A, a novel and potent general inhibitor of retroviral reverse transcriptases and cellular DNA polymerases.
    Loya S; Rudi A; Kashman Y; Hizi A
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):85-92. PubMed ID: 10548537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
    Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
    J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory RNA ligand to reverse transcriptase from feline immunodeficiency virus.
    Chen H; McBroom DG; Zhu YQ; Gold L; North TW
    Biochemistry; 1996 May; 35(21):6923-30. PubMed ID: 8639644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interaction of human immunodeficiency virus reverse transcriptase with oligonucleotide derivatives containing polycyclic aromatic groups at the 5'-terminus].
    Zakharova OD; Mart'ianov IV; Timofeeva OA; Sottofattori E; Pyshnyĭ DV; Balbi A; Litvak S; Tarrago-Litvak L; Nevinskiĭ GA
    Mol Biol (Mosk); 1997; 31(2):373-9. PubMed ID: 9213768
    [No Abstract]   [Full Text] [Related]  

  • 12. Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass.
    Cancio R; Spadari S; Maga G
    Biochem J; 2004 Nov; 383(Pt. 3):475-82. PubMed ID: 15315477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent binding of elliptinium acetate (NSC 264137) to nucleic acids of L1210 cells in culture.
    Dugue B; Auclair C; Meunier B
    Cancer Res; 1986 Aug; 46(8):3828-33. PubMed ID: 2425935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligonucleotides and their derivatives as tools for investigations of protein-nucleic acid interactions in template biocatalysis.
    Lavrik OI
    Nucleic Acids Symp Ser; 1991; (24):185-8. PubMed ID: 1726742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-nucleoside anti-HIV-1 reverse transcriptase inhibitors (NNRTIs): a chemical survey from lead compounds to selected drugs for clinical trials.
    Artico M
    Farmaco; 1996 May; 51(5):305-31. PubMed ID: 8767842
    [No Abstract]   [Full Text] [Related]  

  • 16. Quaternary benzo[c]phenanthridine alkaloids--novel cell permeant and red fluorescing DNA probes.
    Slaninová I; Slanina J; Táborská E
    Cytometry A; 2007 Sep; 71(9):700-8. PubMed ID: 17549765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A full-coordinate model of the polymerase domain of HIV-1 reverse transcriptase and its interaction with a nucleic acid substrate.
    Setlik RF; Meyer DJ; Shibata M; Roskwitalski R; Ornstein RL; Rein R
    J Biomol Struct Dyn; 1994 Aug; 12(1):037-60. PubMed ID: 7531452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conformation of crystalline 3'-nitro-2',3'-dideoxythymidine and properties of its 5'-triphosphate as a terminator substrate of retroviral reverse transcriptase].
    Kuznetsova EV; Kukhanova MK; Gurskaia GV; Fedorov II; Ias'ko MV; Chattopadiiyaya J; Kraevskiĭ AA
    Mol Biol (Mosk); 1995; 29(2):407-14. PubMed ID: 7540254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nigranoic acid, a triterpenoid from Schisandra sphaerandra that inhibits HIV-1 reverse transcriptase.
    Sun HD; Qiu SX; Lin LZ; Wang ZY; Lin ZW; Pengsuparp T; Pezzuto JM; Fong HH; Cordell GA; Farnsworth NR
    J Nat Prod; 1996 May; 59(5):525-7. PubMed ID: 8778243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reverse transcription and its significance in genetics and oncology].
    Gershenzon SM
    Usp Sovrem Biol; 1973; 75(3):323-39. PubMed ID: 4126002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.